Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Recompensation and Stable Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness Combined With Non-Invasive Markers: A Prospective, Observational, Multicenter Study

NCT07087041 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT07087041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07087041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Recompensation and Stable Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness Combined With Non-Invasive Markers: A Prospective, Observational, Multicenter Study
Lead sponsor
Beijing Friendship Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
July 15, 2025
Completion date
December 30, 2028
Enrollment
735 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol-related liver disease, decompensated cirrhosis, hepatitis b virus (hbv) infection, metabolic dysfunction-associated steatotic liver disease (masld), portal hypertension, recompensation